Production & Traceability · 03 of 08

From Seed to Supplement

Six controlled stages take a bitter apricot kernel from orchard byproduct to pharmaceutical-grade amygdalin — traceable, tested, and ready for distribution.

Process at a glance

1
Sourcing
2
Shelling
3
Cold-press
4
Extraction
5
Testing
6
Distribution

Production Stages

Six Steps from Orchard to Capsule

01
Stage 01
Kernel Sourcing & Selection

Bitter apricot kernels (Prunus armeniaca var. amara) sourced as a byproduct of the food processing industry in Central Asia and the Mediterranean. Only bitter cultivars accepted — sweet varieties contain negligible amygdalin. Each incoming lot is inspected for moisture content, contamination, and integrity.

Origin: Central Asia Variety: bitter amara Incoming QC
Apricot kernels on a lab tray with magnifying glass for QC inspection
02
Stage 02
Shelling & Testa Removal

Kernels are mechanically cracked to remove the hard endocarp (stone shell). The inner seed is then dehulled to strip the thin testa (seed coat), exposing the pale cotyledon tissue and maximising extraction efficiency.

Mechanical dehulling Testa removed Cotyledon isolated
Cracked apricot pits showing the inner kernel seeds after shelling
03
Stage 03
Cold-Press Oil Separation

Cotyledon tissue contains 45–55% fixed oil by weight. A cold-press step expels this oil before extraction. The separated kernel oil is a secondary product. The resulting press cake retains the glycoside fraction intact.

Cold-press ≤40°C max Oil yield ~45% Glycoside preserved
Cold press machine extracting oil from apricot kernels with press cake beside it
04
Stage 04
Amygdalin Extraction & Purification

The defatted press cake undergoes aqueous extraction. The extract is filtered, concentrated, and purified through precipitation and crystallisation steps to remove co-extracted proteins and polyphenols, yielding a standardised amygdalin fraction.

Aqueous extraction Filtration Crystallisation Purity standardised
Laboratory flasks and funnel showing amygdalin extraction and crystallisation process
05
Stage 05
Independent Laboratory Testing

Every production lot is submitted to independent third-party laboratory analysis before release. Testing confirms identity, purity, and absence of contaminants. A Certificate of Analysis (COA) is issued per lot and accompanies every shipment.

HPLC identity Heavy metals Microbial limits COA per lot
Vial rack with laboratory samples and Certificate of Analysis document
06
Stage 06
Filling, Packaging & Distribution

Purified amygdalin is filled into final form — 100 mg or 500 mg oral tablets, or 3 g/10 ml injectable solution — under controlled conditions. Cold-chain packaging available for injectable product. Ships internationally from TJ Supply's US facility.

100 mg & 500 mg tablets 3 g/10 ml injectable Cold-chain available Ships from USA
Packaged tablets, injectable vials, and shipping boxes ready for distribution

By the numbers

Production Parameters

Final Forms
3
Tablets 100 mg · 500 mg · Injectable 3 g/10 ml
Cold-Press Temp
≤40°C
Preserves glycoside integrity during oil separation
QC Checkpoints
3
Incoming lot · post-extraction · pre-release COA
Traceability
Lot #
Every shipment traceable to source batch
Experience
25+
Years distributing pharmaceutical-grade amygdalin
Distribution
USA
Ships internationally · cold-chain available

TJ Supply — Since 2001

Novodalin® — The End Product

Pharmaceutical-grade amygdalin standardized at ≥98% purity by HPLC. Each lot ships with a Certificate of Analysis traceable from kernel source to final tablet.

Tablets 100 mg & 500 mg Injectable 3g/10ml Certificate of Analysis per lot HPLC-verified ≥98% purity GMP certified manufacturing Ships worldwide from San Ysidro, CA
Important Safety Note

Amygdalin/Laetrile is not FDA-approved as a cancer treatment or preventive. Raw apricot kernels should be consumed with caution due to cyanide risk. This page describes the industrial extraction process for educational reference — not medical guidance.

Sources: TJ Supply production documentation, PMC/NIH phytochemistry literature, European Food Safety Authority (EFSA)

Process overview for sourcing & compliance reference — not a medical or regulatory claim. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Continue the Series

Explore more infographics or shop the finished Novodalin® supplement line.